Breaking Barriers in Cancer Care: The Global Outlook of the CART Cell Therapy Market
Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy that uses the body's own immune system to fight cancer. In CAR T-cell therapy market , T cells are removed from the patient's blood, genetically engineered to express a chimeric antigen receptor (CAR), and then infused back into the patient. The CAR is designed to recognize a specific cancer antigen, and the T cells are...
0 Comments
0 Shares